![](/img/cover-not-exists.png)
Corrigendum to “A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study” [Gynecol. Oncol. 116 (2010)]
Thomas F. Rocereto, William E. Brady, Mark S. Shahin, James S. Hoffman, Laurie Small, Jacob Rotmensch, Robert S. MannelVolume:
118
Year:
2010
Language:
english
DOI:
10.1016/j.ygyno.2010.04.019
File:
PDF, 90 KB
english, 2010